Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales139 367153 290177 526183 869192 013201 410
EBITDA10 60411 90813 05312 54313 08313 370
Operating profit (EBIT)9 19110 42711 37310 08310 51110 775
Pre-Tax Profit (EBT)------
Net income4 6445 2375 3175 2555 6825 920
P/E ratio24,321,116,114,612,911,6
EPS ( $ )3,964,634,905,025,696,30
Dividend per Share ( $ )1,101,401,701,992,242,67
Yield1,14%1,43%2,15%2,72%3,07%3,65%
Reference price ( $ )96.3197.7778.9173.0973.0973.09
Announcement Date02/10/2015
12:00pm
02/09/2016
11:51am
02/09/2017
11:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt10 44024 91724 07324 51722 38822 110
Finance------
Operating income (EBITDA)10 60411 90813 05312 54313 08313 370
Leverage
(Debt/EBITDA)
0,98x2,09x1,84x1,95x1,71x1,65x
Capital Expenditure2 1362 3672 2242 0742 2072 171
Book Value Per Share (BVPS)33,3 $33,8 $34,7 $35,0 $37,3 $38,7 $
Cash Flow per Share6,96 $7,47 $9,33 $8,07 $8,82 $9,70 $
Announcement Date02/10/2015
12:00pm
02/09/2016
11:51am
02/09/2017
11:55am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 74 040 M$ -
Entreprise Value (EV) 98 557 M$ 96 427 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 14,6x 12,9x
Capitalization / Revenue 0,40x 0,39x
EV / Revenue 0,54x 0,50x
EV / EBITDA 7,86x 7,37x
Yield (DPS / Price) 2,72% 3,07%
Price to book (Price / BVPS) 2,09x 1,96x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 5,48% 5,47%
operating Leverage (Delta EBIT / Delta Sales) - 0,96x
Net Margin (Net Profit / Revenue) 2,86% 2,96%
ROA (Net Profit / Asset) 6,04% 6,34%
ROE (Net Profit / Equities) 15,5% 16,5%
Rate of Dividend 39,6% 39,4%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,13% 1,15%
Cash Flow / Sales 4,45% 4,65%
Capital Intensity (Assets / Sales) 0,47x 0,47x
Financial Leverage (Net Debt / EBITDA) 1,95x 1,71x
EPS & Dividend